Brookdale Senior Living (BKD) reported June and second quarter 2026 occupancy metrics that showed both year-over-year and sequential growth, highlighting higher resident demand across its senior living communities.

See our latest analysis for Brookdale Senior Living.

These occupancy gains have come alongside strong market interest in Brookdale Senior Living, with the share price delivering a 38.47% year to date share price return and a very large 3 year total shareholder return as investors react to improving operations and recent debt refinancing.

If stronger occupancy has you thinking about where else capital is flowing in healthcare, it may be worth scanning a wider set of healthcare AI opportunities via our stock screener, starting with 39 healthcare AI stocks.

After a 38.47% share price move this year and a very large 3 year total return, the real tension around Brookdale Senior Living now is simple: is most of the upside already reflected, or does today’s valuation still leave meaningful room?

Most Popular Narrative: 11.7% Undervalued

At a last close of $15.01 versus a most followed fair value of $17.00, the Brookdale Senior Living narrative leans toward further upside baked into detailed multi year assumptions.

Brookdale's accelerating occupancy rates, now consistently above the critical 80 percent threshold, have led to robust free cash flow generation and rising adjusted EBITDA, signaling that core revenue and earnings power are on an improving long-term trajectory.

The company has demonstrated effective portfolio optimization by shedding underperforming assets and focusing on high-potential communities, which is expected to increase occupancy rates, revenue per occupied room, adjusted EBITDA, and overall net margins over time.

Read the complete narrative.

Want to see what sits behind that $17.00 anchor on Brookdale Senior Living? The narrative leans on steady revenue expansion, margin repair, and a richer earnings multiple. Curious which assumptions really carry the weight.

Result: Fair Value of $17.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Brookdale Senior Living still faces pressure from rising labor costs and an aging facility base, which could require heavier investment and weigh on margins.

Find out about the key risks to this Brookdale Senior Living narrative.

Another View: Brookdale Senior Living Through a Sales Multiple Lens

The SWS DCF model points to a value of $9 per share for Brookdale Senior Living, which sits well below both the $17.00 fair value narrative and the recent $15.01 share price. This approach frames the stock as overvalued rather than 11.7% undervalued.

That kind of gap between a cash flow model and a story built on occupancy and margin repair raises a practical question for you as an investor: which set of assumptions feels more realistic if sentiment cools or execution stumbles?

Look into how the SWS DCF model arrives at its fair value.

Next Steps

If the mixed sentiment around Brookdale Senior Living has you unsure, take a moment to review the numbers, weigh both sides, and act before views shift further, starting with the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Brookdale Senior Living?

If Brookdale Senior Living has sharpened your focus, use the Simply Wall St screener to spot fresh opportunities before the crowd does and keep your watchlist evolving.

• Target potential value opportunities by scanning 47 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their underlying strength.
• Prioritize resilience by reviewing 82 resilient stocks with low risk scores that show lower risk scores and may help balance out more volatile positions in your portfolio.
• Hunt for future standouts by checking the screener containing 20 high quality undiscovered gems that the wider market may not be focusing on yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.